User:Molmed08
From Wikipedia, the free encyclopedia
Molecular Medicine (journal) Editors-in-Chief: Kevin J. Tracey, MD, and Anthony Cerami, PhD Managing Editor: Christopher J. Czura, MS Associate Editor: Margot Gallowitsch-Puerta, MS Editorial Assistant: Virgina Duryea Design and Web Development: Kathy Stroud Production: Wendy B Passerell
The world of scientific publications has seen dramatic change over the past several years with increasing emphasis on Web-based manuscript submission processes and online open access. The Feinstein Institute for Medical Research, dedicated to disseminating scientific ideas and discoveries, publishes the peer-reviewed journal Molecular Medicine. This open-access journal is focused on understanding the pathogenesis of disease at the molecular level and translating this knowledge into specific molecular tools for diagnosis, treatment and prevention.
Founded in 1994, Molecular Medicine serves as a forum through which scientists and researchers can communicate recent discoveries to a multi-disciplinary, international audience interested in understanding and curing disease. Co-editors Kevin J. Tracey, MD (The Feinstein Institute for Medical Research, Manhasset, NY) and Anthony Cerami, PhD (Warren Pharmaceuticals, Ossining, NY), have enacted a Board of Contributing Editors who are world-renowned scientists in their respective fields. In addition to reviewing papers submitted to Molecular Medicine to ensure that only novel, groundbreaking discoveries are accepted for publication, contributing editors also solicit manuscripts from their peers, coordinate the peer review process and submit accepted papers directly to the journal’s editorial office for publication.
Molecular Medicine publishes ahead of print-production schedules. Soon after acceptance, papers are published online and listed in PubMed and PubMed Central, two of the most-frequented online search engines used by researchers around the world. On the journal’s Web site – www.molmed.org – readers have open, full-text access to all publications dating back to 2000. Success of Molecular Medicine is reflected in its “impact factor,” a ranking of journals based on the frequency with which scientists refer to it. The impact factor of Molecular Medicine for 2007 is 2.708, placing it in the top 16 percent of more than 6,000 peer-reviewed international journals.
Molecular Medicine is dedicated to fostering interdisciplinary communication and collaboration. The use of evolving communication technology has allowed us to better make those connections. Our new podcast, “Mollie Medcast,” has been a great success. The establishment of our online Molecular Medicine Frappr Map has begun to cultivate a global community where users may communicate openly with one another. Our RSS feed automatically delivers updated Molecular Medicine content to users and our online manuscript submission system accommodates international authors and reviewers 24 hours a day in a virtual office environment.
We begin our 14th year by announcing “The Centricity Series.” Molecular Medicine will produce a compendium lecture series covering cutting edge biomedical research on complex diseases such as sepsis, cancer, Alzheimer’s, arthritis and lupus. All lectures will be archived as high quality audio, slides and photography and be available through the Molecular Medicine website. Transcripts from every lecture, biosketches of each speaker and links to their laboratory and current work will also be available. The first installment, The Centricity Series: Sepsis, is in production and will be available in the coming months.
More than just a resource, The Centricity Series will become a point of convergence, a rallying point for dedicated professionals. Beyond disease-specific landmark papers, Molecular Medicine will expand the range of invited submissions to include short-form articles and comments and reader-suggested “hot links” to related research websites, breaking news and related publications. Future plans include live webinars and objective-specific bulletin boards, chat rooms and interactive conferences among peers.
A fundamental aspect of biomedical research is communication. Discoveries are seldom made in isolation and, even if they are, cannot effectively be used to help patients if knowledge of the discoveries is not spread to other researchers. An explosion of new technologies in the field of molecular medicine has driven the field forward, and now requires investigators from vastly different backgrounds – physicians, epidemiologists, geneticists and basic scientists – to communicate their findings to a wide audience using a common language and forum. Standing at the crossroads of medicine and science, Molecular Medicine is an instrumental mechanism for the dissemination of such findings.
External Links Molecular Medicine homepage Molecular Medicine podcast
